A novel phage-based blood assay has demonstrated its potential for identifying people at high-risk of developing tuberculosis, in addition to diagnosing established cases.
Browsing: Clinical > Diagnosis
In this interview we speak to David Padley from the National Institute for Biological Standards and Control about his recent poster ‘Point-of-Care testing for HIV: specialist quality control materials are a necessity’, presented at ECCMID 2019.
New research has identified four novel sepsis phenotypes, suggesting these could be relevant for understanding the heterogeneity of treatment effects and help to explain recent clinical trial failures.
The ECDC has reported that the burden of healthcare-associated infections is substantial and variability in microbiological testing suggests these infections could be managed better, according to research presented at ECCMID.
Research presented at ECCMID has highlighted large variations in mortality rate associated with different bloodstream infections, as well as the threat posed by these infections.
Only one-third of patients entering the emergency department with a suspected UTIs actually have evidence of infection, however, almost all were treated with antibiotics, according to research presented at ECCMID.
The accurate diagnosis of schistosomiasis, in both the mammalian and snail intermediate hosts as well as the environment, is extremely important in proper control and elimination. Despite multiple efforts over last few decades, the search for cheap, sensitive diagnostics for schistosomiasis is ongoing.
A new rapid microelectrode device for the earlier diagnosis of sepsis has been developed by researchers at the University of Strathclyde.
Researchers from the Howard Hughes Medical Institute have developed a novel genetic tool for detecting fast and accurate measures of latent HIV.